Malignant pleural mesothelioma (MPM) is an aggressive tumor mainly associated with
asbestos exposure and is characterized by a very difficult pharmacological approach. One of …

Modulation of histone methylation status is regarded as an important mechanism of
epigenetic regulation and has substantial clinical potential for the therapy of diseases …

Malignant mesothelioma (MESO) is a highly aggressive cancer with poor prognosis.
Epithelial–mesenchymal transition (EMT) is a critical process in malignancies involved in …

Malignant mesothelioma (MESO) consists of epithelioid, biphasic, and sarcomatoid
subtypes with different epithelial–mesenchymal transition (EMT) phenotypes. We previously …

Introduction Pleural mesothelioma is a rare and aggressive cancer originating in the pleura,
with a devastating prognosis and limited treatment options. There have been significant …

Pleural mesothelioma (PM) is characterized by rapid growth, local invasion, and limited
therapeutic options. The multifunctional oncoprotein Y‐box‐binding protein‐1 (YB‐1) is …

Mechanical stimulation is the key physical factor in cell environment. Mechanotransduction
acts as a fundamental regulator of cell behavior, regulating cell proliferation, differentiation …

恶性胸膜间皮瘤（ malignant pleural mesothelioma, MPM） 是侵袭性极强的罕见胸膜表面恶性
肿瘤， 危险因素包括吸入石棉、 遗传因素、 基因突变等。 现有的化疗、 抗血管生成治疗 …

恶性胸膜间皮瘤(malignant pleural mesothelioma, MPM) 是侵袭性极强的罕见胸膜表面恶性
肿瘤, 危险因素包括吸入石棉, 遗传因素, 基因突变等. 现有的化疗, 抗血管生成治疗 …

Malignant mesotheliomas (MM) are hard to treat malignancies with poor prognosis and high
mortality rates. This cancer is highly misdiagnosed in Sub-Saharan African countries …